How long should bedaquiline treatment be continued?

The period of use of Bedaquiline is not indefinite, and its duration is usually affected by multiple factors such as the treatment plan, the type of drug-resistant tuberculosis bacteria, and the patient's individual response. According to international authoritative guidelines, including standard treatment regimens recommended by the World Health Organization (WHO), bedaquiline is often used in the initial stage of multidrug-resistant pulmonary tuberculosis treatment with a clear time limit. Generally speaking, the duration of continuous use of bedaquiline during the entire treatment cycle is about six months, that is, 24 weeks. This length of time is considered to be the balance point that maximizes the efficacy while controlling the risk of drug toxicity.

Bedaquiline is administered in stages, usually once daily for the first two weeks, then three times weekly. The setting of this dosing rhythm is based on the pharmacokinetic properties of the drug, that is, its half-life in the body is long. Maintaining the concentration can achieve stable blood drug levels by adjusting the dosing frequency and reduce the cumulative risk of adverse reactions such as hepatotoxicity and QT interval prolongation. Although some studies have explored extending the use time of bedaquiline to nine months or even one year to improve efficacy, current international treatment standards generally recommend six months as the recommended limit, unless special clinical circumstances clearly indicate that it can be extended.

It should be noted that bedaquiline cannot be used alone; it is always used as part of a combination anti-tuberculosis treatment regimen with other drugs, such as linezolid, levofloxacin or delamanid. The principle of combined drug use is to reduce the risk of drug resistance and improve the cure rate, while reducing the toxicity of each drug. Patients must follow the doctor's instructions during the entire treatment process and cannot arbitrarily extend or shorten the medication cycle to prevent recurrence of the disease or worsening of drug resistance.

Reference materials:https://en.wikipedia.org/wiki/Bedaquiline